Fayad LE - Search Results

1

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.

Hu B, Younes A, Westin JR, Turturro F, Claret L, Feng L, Fowler N, Neelapu S, Romaguera J, Hagemeister FB, Rodriguez MA, Samaniego F, Fayad LE, Copeland AR, Nastoupil LJ, Nieto Y, Fanale MA, Oki Y. Hu B, et al. Among authors: fayad le. Leuk Lymphoma. 2018 Apr;59(4):863-870. doi: 10.1080/10428194.2017.1359741. Epub 2017 Aug 9. Leuk Lymphoma. 2018. PMID: 28792260 Clinical Trial.

2

Hodgkin's disease variant of Richter's syndrome: experience at a single institution.

Fayad L, Robertson LE, O'Brien S, Manning JT, Wright S, Hagemeister F, Cabanillas F, Keating MJ. Fayad L, et al. Leuk Lymphoma. 1996 Oct;23(3-4):333-7. doi: 10.3109/10428199609054836. Leuk Lymphoma. 1996. PMID: 9031114

3

High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.

Fayad L, Cabanillas F, Talpaz M, McLaughlin P, Kurzrock R. Fayad L, et al. Leuk Lymphoma. 1998 Aug;30(5-6):563-71. doi: 10.3109/10428199809057568. Leuk Lymphoma. 1998. PMID: 9711918

4

Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.

Rodriguez J, McLaughlin P, Hagemeister FB, Fayad L, Rodriguez MA, Santiago M, Hess M, Romaguera J, Cabanillas F. Rodriguez J, et al. Blood. 1999 Apr 1;93(7):2202-7. Blood. 1999. PMID: 10090928 Free article.

5

ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.

Rodriguez J, Rodriguez MA, Fayad L, McLaughlin P, Swan F, Sarris A, Romaguera J, Andersson B, Cabanillas F, Hagemeister FB. Rodriguez J, et al. Blood. 1999 Jun 1;93(11):3632-6. Blood. 1999. PMID: 10339468 Free article. Clinical Trial.

6

Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981.

Rodriguez J, McLaughlin P, Fayad L, Santiago M, Hess M, Rodriguez MA, Romaguera J, Hagemeister F, Kantarjian H, Cabanillas F. Rodriguez J, et al. Ann Oncol. 2000 Dec;11(12):1551-6. doi: 10.1023/a:1008330311886. Ann Oncol. 2000. PMID: 11205462 Free article.

7

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.

Schlembach PJ, Wilder RB, Jones D, Ha CS, Fayad LE, Younes A, Hagemeister F, Hess M, Cabanillas F, Cox JD. Schlembach PJ, et al. Among authors: fayad le. Cancer J. 2002 Sep-Oct;8(5):377-83. doi: 10.1097/00130404-200209000-00008. Cancer J. 2002. PMID: 12416895

8

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD. Chronowski GM, et al. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):36-43. doi: 10.1016/s0360-3016(02)03915-9. Int J Radiat Oncol Biol Phys. 2003. PMID: 12504034

9

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.

Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, Younes A, McLaughlin P, Goy A, Sarris AH, Dang NH, Samaniego F, Brown HM, Gagneja HK, Cabanillas F. Romaguera JE, et al. Among authors: fayad le. Cancer. 2003 Feb 1;97(3):586-91. doi: 10.1002/cncr.11096. Cancer. 2003. PMID: 12548600 Free article.

10

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.

Hosing C, Saliba RM, McLaughlin P, Andersson B, Rodriguez MA, Fayad L, Cabanillas F, Champlin RE, Khouri IF. Hosing C, et al. Ann Oncol. 2003 May;14(5):737-44. doi: 10.1093/annonc/mdg200. Ann Oncol. 2003. PMID: 12702528 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page